Trial intelligence / Profile preview

Autologous Bone Marrow Clot for Posterior Lumbar Fusion

NCT05936047Completed

Sponsor
Istituto Ortopedico Rizzoli
Start
Nov 2020
Primary completion
Jul 2022
Countries
1
01

Overview

Open-label, single-arm trial in Degenerative spine disease, sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Brantigan classification at 12 months. Started Nov 2020; status: completed.

02

Conditions

Degenerative spine disease

Beyond the preview

Go deeper on NCT05936047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05936047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call